![Jian Irish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jian Irish
Algemeen Directeur bij
METAGENOMI THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-06-2026
Profiel
Jian Irish is President, Chief Executive Officer & Director at Metagenomi Therapeutics, Inc. since 2025.
Former roles include Chief Technology Officer & Director at Fosun Kite Biotechnology Co., Ltd. from 2018 to 2020; Executive Director-Contract Manufacturing at Amgen, Inc. from 2000 to 2014; Chief Operating Officer at Metagenomi Technologies LLC in 2021; Chief Operating Officer at Affini-T Therapeutics, Inc. from 2021 to 2022; Vice President-Biologics Supply & Partnerships at Sanofi from 2015 to 2016; and Senior Vice President & Global Head-Manufacturing at Kite Pharma, Inc. from 2016 to 2020.
Education includes graduate and doctorate degrees from Chiba University, an undergraduate degree from East China University of Science & Technology, and an MBA from UCLA Anderson School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-06-2026 | 962.960 ( 2,56% ) | 1 M $ | 30-06-2026 |
Actieve functies van Jian Irish
| Bedrijven | Functie | Begin |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Algemeen Directeur | 11-11-2025 |
Eerdere bekende functies van Jian Irish
| Bedrijven | Functie | Einde |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Operationeel Directeur | 01-01-2022 |
| KITE PHARMA INC | Corporate Officer/Principal | 01-12-2020 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
| SANOFI | Corporate Officer/Principal | 01-08-2016 |
| AMGEN INC. | Corporate Officer/Principal | 01-09-2014 |
Opleiding van Jian Irish
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
80
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Chiba University
 Chiba University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
Kies MarketScreener 
